Müller Michael, Koch Frank, Singh Pankaj, Kohnen Thomas
Klinik für Augenheilkunde, Universitätsklinikum Frankfurt, Theodor Stern Kai 7, 60590, Frankfurt am Main, Deutschland.
Ophthalmologe. 2021 Jan;118(1):56-59. doi: 10.1007/s00347-020-01085-7.
After an uneventful intravitreal injection (IVI) of Ocriplasmin in a patient with reduced visual acuity due to vitreomacular traction (VMT) and a small macular hole, retinal detachment occurred within a few days after the operation. Although retinal detachment is known as a risk factor of IVI this case is noteworthy: an excessive reaction occurred in the region of the vitreous body, which resulted in the development of severe traction on the retina leading to a posterior vitreous body detachment, retinal holes and complete retinal detachment. This possible complication should be discussed in the preoperative patient informed consent and the reason for this excessive reaction should be the subject of further investigations.
在一名因玻璃体黄斑牵引(VMT)和小黄斑裂孔导致视力下降的患者进行了一次顺利的玻璃体内注射(IVI)奥克纤溶酶后,术后几天内发生了视网膜脱离。虽然视网膜脱离是IVI的已知风险因素,但该病例值得注意:玻璃体区域发生了过度反应,导致视网膜受到严重牵引,进而导致玻璃体后脱离、视网膜裂孔和完全性视网膜脱离。这种可能的并发症应在术前患者知情同意书中进行讨论,而这种过度反应的原因应作为进一步研究的主题。